Robert W. Baird Issues Pessimistic Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price

iRhythm Technologies (NASDAQ:IRTC) had its target price lowered by research analysts at Robert W. Baird from $220.00 to $200.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price target indicates a potential upside of 32.49% from the company’s current price.

A number of other research analysts have also issued reports on the company. Evercore upgraded iRhythm Technologies from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $194.00 to $210.00 in a report on Monday, January 5th. JPMorgan Chase & Co. increased their price target on iRhythm Technologies from $190.00 to $240.00 and gave the company an “overweight” rating in a research report on Friday, October 31st. BTIG Research lifted their price objective on iRhythm Technologies from $195.00 to $215.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Needham & Company LLC reissued a “buy” rating and set a $244.00 price objective on shares of iRhythm Technologies in a research report on Monday, January 12th. Finally, The Goldman Sachs Group upped their target price on shares of iRhythm Technologies from $180.00 to $202.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, iRhythm Technologies currently has an average rating of “Moderate Buy” and an average price target of $211.62.

iRhythm Technologies Trading Down 5.0%

Shares of IRTC stock opened at $150.96 on Friday. iRhythm Technologies has a fifty-two week low of $92.52 and a fifty-two week high of $212.00. The company has a 50 day moving average price of $164.65 and a 200 day moving average price of $171.37. The stock has a market capitalization of $4.86 billion, a P/E ratio of -107.83 and a beta of 1.06. The company has a debt-to-equity ratio of 5.32, a quick ratio of 4.50 and a current ratio of 4.63.

iRhythm Technologies (NASDAQ:IRTC) last issued its quarterly earnings results on Thursday, February 19th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.02 by $0.27. The company had revenue of $208.89 million during the quarter, compared to analysts’ expectations of $202.61 million. iRhythm Technologies had a negative net margin of 5.96% and a negative return on equity of 31.44%. The firm’s revenue was up 27.1% compared to the same quarter last year. During the same quarter last year, the company posted ($0.04) EPS. Equities research analysts predict that iRhythm Technologies will post -1.98 EPS for the current fiscal year.

Insider Activity

In other iRhythm Technologies news, insider Patrick Michael Murphy sold 2,478 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $184.83, for a total value of $458,008.74. Following the transaction, the insider directly owned 53,281 shares in the company, valued at $9,847,927.23. This represents a 4.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Chad Patterson sold 280 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $184.83, for a total transaction of $51,752.40. Following the sale, the insider owned 43,387 shares of the company’s stock, valued at $8,019,219.21. This represents a 0.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.10% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Quantbot Technologies LP acquired a new position in iRhythm Technologies in the 2nd quarter valued at $3,578,000. Federated Hermes Inc. boosted its holdings in shares of iRhythm Technologies by 45.4% in the third quarter. Federated Hermes Inc. now owns 70,401 shares of the company’s stock valued at $12,108,000 after acquiring an additional 21,977 shares in the last quarter. Osaic Holdings Inc. boosted its holdings in shares of iRhythm Technologies by 507.3% in the second quarter. Osaic Holdings Inc. now owns 9,292 shares of the company’s stock valued at $1,431,000 after acquiring an additional 7,762 shares in the last quarter. Jump Financial LLC acquired a new position in shares of iRhythm Technologies during the second quarter worth about $9,668,000. Finally, Walleye Capital LLC purchased a new position in iRhythm Technologies during the second quarter worth about $11,366,000.

Key Headlines Impacting iRhythm Technologies

Here are the key news stories impacting iRhythm Technologies this week:

• Positive Sentiment: Q4 results beat estimates — Revenue $208.9M (+27.1% YoY) and EPS $0.29 topped consensus; management reported record quarterly revenue, improved gross margin and positive GAAP net income for the quarter. Globe Newswire: Q4 Results
• Positive Sentiment: Beating the street — Third‑party coverage highlights the earnings and revenue beat and improved profitability metrics (adjusted EBITDA, cash flow). These operational improvements support upside case over time. Zacks: Earnings Beat
• Neutral Sentiment: Company materials available — Earnings call transcript and slide deck published for investors to evaluate management commentary and forward drivers (AC C presentations and upcoming data cadence). Useful for confirming guidance/assumptions. Seeking Alpha: Call Transcript
• Neutral Sentiment: Market coverage noted positive market reaction after the print in some outlets — short-term sentiment can swing quickly as investors parse details. MassDevice: Market Reaction
• Negative Sentiment: Analysts trimmed price targets across several firms today (Canaccord, JPMorgan, Wells Fargo, Robert W. Baird) — ratings remain generally positive/overweight but lower targets reduce near‑term upside expectations and can pressure the stock. Benzinga: Analyst Target Changes
• Negative Sentiment: Insider selling and institutional rebalancing highlighted — multiple insider sales and large shifts in fund holdings raise concern about near-term selling pressure and supply overhang. Quiver: Insider & Institutional Activity

About iRhythm Technologies

iRhythm Technologies, Inc is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians.

The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders.